| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/16/2003 | EP1302533A1 Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof |
| 04/16/2003 | EP1302532A1 Method for increasing the growth rate of cells in static liquid culture |
| 04/16/2003 | EP1302203A1 Stem cell reinforcing material |
| 04/16/2003 | EP1301798A2 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 04/16/2003 | EP1301795A2 Method of identifying and/or isolating stem cells |
| 04/16/2003 | EP1301631A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 04/16/2003 | EP1301615A2 Adenovirus vectors comprising introns |
| 04/16/2003 | EP1301614A1 Codon-optimized papilloma virus sequences |
| 04/16/2003 | EP1301613A2 Modified virus having an altered tropism |
| 04/16/2003 | EP1301612A2 Method and composition for targeting an adenoviral vector |
| 04/16/2003 | EP1301611A2 Human rrp sequences and methods of use |
| 04/16/2003 | EP1301606A1 Expression system |
| 04/16/2003 | EP1301605A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 04/16/2003 | EP1301604A2 Substrates and assays for beta-secretase activity |
| 04/16/2003 | EP1301602A2 Fh-binding protein of streptococcus pneumoniae |
| 04/16/2003 | EP1301599A2 Olfactory g-protein coupled receptor |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301593A2 ANTISENSE COMPOSITIONS TARGETED TO $g(b) 1? ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 04/16/2003 | EP1301592A2 Recombinant bacterial phytases and uses thereof |
| 04/16/2003 | EP1301590A2 Stem cell-like cells |
| 04/16/2003 | EP1301589A1 Culturing pancreatic stem cells having a specified, intermediate stage of development |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301538A2 Artificial antibody polypeptides |
| 04/16/2003 | EP1301535A2 G-protein coupled receptors |
| 04/16/2003 | EP1301525A1 Transforming growth factor beta (tgf-beta) blocking agent-treated stem cell composition and method |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301214A2 Methods of transducing neural cells using lentivirus vectors |
| 04/16/2003 | EP1301206A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 04/16/2003 | EP1301205A1 High fidelity polymerases and uses thereof |
| 04/16/2003 | EP1301146A2 Artificial vascular grafts, and methods of producing and using same |
| 04/16/2003 | EP1009442B1 Improvements in or relating to regulation of t cell activation |
| 04/16/2003 | EP0960209A4 Editing-based selectable plastid marker genes |
| 04/16/2003 | EP0927052B1 Bladder submucosa seeded with cells for tissue reconstruction |
| 04/16/2003 | EP0918455B1 Use of galanin to repair nerve damage |
| 04/16/2003 | EP0871483B1 Helper virus-free aav production |
| 04/16/2003 | EP0869803B1 Allogeneic paracrine cytokine tumor vaccines |
| 04/16/2003 | EP0789591B1 Methods for identifying individuals suffering from a cellular abnormality |
| 04/16/2003 | EP0788381B1 Biomaterial containing epithelial cells and use thereof as a transplant |
| 04/16/2003 | EP0749443B1 Fk-506 cytosolic binding protein |
| 04/16/2003 | EP0667896B1 Direct selection of cells by secretion product |
| 04/16/2003 | EP0654083B1 Ptp-d subfamily of protein tyrosine phosphatases |
| 04/16/2003 | EP0642356B1 Antibodies to p-selectin and their uses |
| 04/16/2003 | EP0605442B1 Recombinant antibodies for human therapy |
| 04/16/2003 | EP0591462B1 Universal donor cells |
| 04/16/2003 | CN1411556A Synergistic activation of regulatory elements by Rel proteins and steroid receptor |
| 04/16/2003 | CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them |
| 04/16/2003 | CN1411511A Monocotyledonous plant genes and uses thereof |
| 04/16/2003 | CN1411504A Liver tissue source |
| 04/16/2003 | CN1411471A Macroporous chitosan beads and preparation method thereof |
| 04/16/2003 | CN1411470A Transgenic mice expressing fluorescent protein |
| 04/16/2003 | CN1410532A Establishment of human/goat liver inosculating model and its identification method |
| 04/16/2003 | CN1410531A Culturing method of human peripheral blood vessel endothelial ancestry cell |
| 04/16/2003 | CN1410530A Method of differentiating bone marrow interstitial cell into neuron cell by Chinese medicine inducing |
| 04/16/2003 | CN1410529A In vitro reconstituted human erythrocyte, its preparation and application in blood substitute material |
| 04/16/2003 | CN1105728C Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
| 04/16/2003 | CA2400265A1 Enzyme solution for culturing primate embryonic stem cells and method of culturing using it |
| 04/15/2003 | US6548741 Developmental competence for assisted reproduction and nuclear transfer in pigs |
| 04/15/2003 | US6548740 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example |
| 04/15/2003 | US6548739 Method for activating peroxisome proliferator activated receptor-γ |
| 04/15/2003 | US6548738 Transgenic rodent for use as an animal model in the study of fat metabolism |
| 04/15/2003 | US6548735 5'-flanking sequence such as beta-lactoglobulin and DNA coding for a serine protease such as alpha1-antitrypsin or a blood factor |
| 04/15/2003 | US6548653 Erythropoietin analog-human serum albumin fusion |
| 04/15/2003 | US6548642 Expression of synthetic genes designed from repetitive peptide sequences of hydroxyproline-rich glycoproteins |
| 04/15/2003 | US6548633 Complementary DNA's encoding proteins with signal peptides |
| 04/15/2003 | US6548632 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548631 Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection |
| 04/15/2003 | US6548630 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 04/15/2003 | US6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury |
| 04/15/2003 | US6548300 From leaf explants via callus phase; genetic engineering; for rapid growth and bioassays with tobacco tissue cultures |
| 04/15/2003 | US6548299 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 04/15/2003 | US6548297 Sheets are frozen in cryoprotectant solution of mono-/di-saccharide; eliminates need to wash cryopreserved components; materials handling |
| 04/15/2003 | US6548296 Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof |
| 04/15/2003 | US6548295 Complex of lipo-viro-particles, method of preparation and applications |
| 04/15/2003 | US6548291 Polynucleotide sequences/transgenic cells of Bacillus thuringiensis |
| 04/15/2003 | US6548286 Methods for increasing the efficiency of recombinant AAV product |
| 04/15/2003 | US6548284 Membrane-bound metalloprotease and soluble secreted form thereof |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548263 Contacting hydroxyl groups on the substrage surface with a bifunctional molecule comprising a hydroxy-reactive group and a nucleophilic group to form a monolayer, applying stencil to the substrate to deposit cell repulsive or adhesive groups |
| 04/15/2003 | US6548262 Hemostasis system-related disorders treatment |
| 04/15/2003 | US6548261 Transfection of neuronal cells with an expression vector comprising one or more oncogenes |
| 04/15/2003 | US6548249 Fusions of scaffold proteins with random peptide libraries |
| 04/15/2003 | US6548241 Storage solution containing photosensitizer for inactivation of biological contaminants |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | US6548059 Promotion of proliferation of adult corneal endothelial cells |
| 04/15/2003 | US6548058 Skin disorders; skin grafting; culture product |
| 04/15/2003 | CA2257101C Dna sequences encoding phytases of ruminal microorganisms |
| 04/15/2003 | CA2034504C Fungal stress proteins |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029464A2 Genes associated with mast cell activation |
| 04/10/2003 | WO2003029461A1 A method of genetic screening using an amplifiable gene |
| 04/10/2003 | WO2003029458A2 Method for producing protein libraries and for selecting proteins from said libraries |
| 04/10/2003 | WO2003029456A1 Multi-chain eukaryotic display vectors and uses thereof |
| 04/10/2003 | WO2003029453A2 Induction of gene expression by silencing of repressor genes |
| 04/10/2003 | WO2003029451A2 Histone deacetylase 9 |
| 04/10/2003 | WO2003029448A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 04/10/2003 | WO2003029447A1 Gene transfer composition and method |
| 04/10/2003 | WO2003029446A2 Methods for producing in-vitro hollow organs |